No Data
Kangtuo Healthcare: Xi\'an Kangtuo Medical Technology Co., Ltd. 2024 Annual Results Express Announcement
Xi\'an Kangtuo Medical Technology Co., Ltd. 2024 Annual Results Express Announcement
Kangtuo Medical (688314.SH): The net income for the year 2024 is 88.5708 million yuan, an increase of 17.30% year-on-year.
On February 25, Gelonghui announced that Kangtuo Medical (688314.SH) released its performance report for the year 2024, showing revenue of 321.9452 million yuan, an increase of 17.06% compared to the same period last year; net income attributable to the parent company was 88.5708 million yuan, an increase of 17.30% year-on-year; and net income attributable to the parent company after deducting non-recurring gains and losses was 75.0325 million yuan, an increase of 9.77% year-on-year. During the reporting period, the net income attributable to the parent company was 88.5708 million yuan, reflecting a 17.3% increase compared to the same period last year.
Kangtuo Medical (688314.SZ): Xi'an Heyi plans to reduce its shareholding by no more than 1.17%.
Kangtuo Medical (688314.SZ) announced that its employee shareholding platform, Xi'an Huying Enterprise Management Consulting Partnership (...
Kangtuo Medical (688314.SH) is distributing equity for the first three quarters of 2024: 0.18 yuan per share will be distributed, with the equity registration on December 3.
Kangtuo Medical (688314.SH) announced the profit distribution for the first three quarters of 2024; this profit distribution is based on...
Kangtuo Medical (688314.SH): Personalized polyether ether ketone skull defect repair prosthesis obtained medical instrument registration certificate.
Concord Medical (688314.SH) announced that the company recently obtained the third pharmaceutical product...
